85 related articles for article (PubMed ID: 1461650)
1. c-myc and p53 gene expression in the differentiation of temperature-sensitive mutants of teratocarcinoma F9 cells.
Kosaka M; Iwai SA; Nishina Y; Sumi T; Nishimune Y
Oncogene; 1992 Dec; 7(12):2455-60. PubMed ID: 1461650
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
Whitman MM; Shen YM; Soprano D; Soprano KJ
Cancer Res; 1990 Jun; 50(11):3193-8. PubMed ID: 2139801
[TBL] [Abstract][Full Text] [Related]
3. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
Wang Y; Szekely L; Okan I; Klein G; Wiman KG
Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of F9 cells is independent of c-myc expression.
Nishikura K; Kim U; Murray JM
Oncogene; 1990 Jul; 5(7):981-8. PubMed ID: 1695728
[TBL] [Abstract][Full Text] [Related]
5. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
6. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
Cory JG; Cory AH; Long SD; Carter GL; Johnson CE
Cancer Res; 1992 Apr; 52(7):2000-3. PubMed ID: 1551129
[TBL] [Abstract][Full Text] [Related]
7. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
8. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
[TBL] [Abstract][Full Text] [Related]
9. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
10. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M.
Liu J; Clegg CH; Shoyab M
Cell Growth Differ; 1992 May; 3(5):307-13. PubMed ID: 1633113
[TBL] [Abstract][Full Text] [Related]
11. Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes.
Gandarillas A; Watt FM
Oncogene; 1995 Oct; 11(7):1403-7. PubMed ID: 7478564
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet irradiation, although it activates the transcription factor AP-1 in F9 teratocarcinoma stem cells, does not induce the full complement of differentiation-associated genes.
Auer HP; König H; Litfin M; Stein B; Rahmsdorf HJ
Exp Cell Res; 1994 Sep; 214(1):131-8. PubMed ID: 7521841
[TBL] [Abstract][Full Text] [Related]
13. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
Onclercq R; Babinet C; Cremisi C
Oncogene Res; 1989; 4(4):293-302. PubMed ID: 2671866
[TBL] [Abstract][Full Text] [Related]
14. Changes in Hox1.6, c-jun, and Oct-3 gene expressions are associated with teratocarcinoma F9 cell differentiation in three different ways of induction.
Iwai SA; Kosaka M; Nishina Y; Sumi T; Sakuda M; Nishimune Y
Exp Cell Res; 1993 Mar; 205(1):39-43. PubMed ID: 8453995
[TBL] [Abstract][Full Text] [Related]
15. Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II).
Marazzi L; Parodi MT; Di Martino D; Ferrari S; Tonini GP
Anticancer Res; 1991; 11(2):947-52. PubMed ID: 2064352
[TBL] [Abstract][Full Text] [Related]
16. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
[TBL] [Abstract][Full Text] [Related]
17. The induction of jun genes during the reversible changes induced with sodium butyrate on the differentiation of F9 cells.
Nishina Y; Sumi T; Iwai SA; Kosaka M; Nishimune Y
Exp Cell Res; 1993 Oct; 208(2):492-7. PubMed ID: 8375477
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of N-myc and c-myc expression in F9 teratocarcinoma cells.
Finklestein R; Weinberg RA
Oncogene Res; 1988; 3(3):287-92. PubMed ID: 3060804
[TBL] [Abstract][Full Text] [Related]
19. TPA-induced differentiation of human rhabdomyosarcoma cells involves dephosphorylation and nuclear accumulation of mutant P53.
Germani A; Fusco C; Martinotti S; Musarò A; Molinaro M; Zani BM
Biochem Biophys Res Commun; 1994 Jul; 202(1):17-24. PubMed ID: 8037710
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
Richon VM; Ramsay RG; Rifkind RA; Marks PA
Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
